Breaking News Instant updates and real-time market news.

LXRX

Lexicon

$2.01

0.59 (41.55%)

08:04
09/11/19
09/11
08:04
09/11/19
08:04

Lexicon upgraded to Buy from Hold at Gabelli

LXRX Lexicon
$2.01

0.59 (41.55%)

07/29/19
STFL
07/29/19
DOWNGRADE
Target $4
STFL
Hold
Lexicon downgraded to Hold from Buy at Stifel
Stifel analyst Stephen Willey downgraded Lexicon Pharmaceuticals to Hold from Buy and cut his price target for the shares to $4 from $10. Sanofi's (SNY) planned sotagliflozin exodus and Phase 3 trials of Zynquista in adults living with type 2 diabetes clouds the company's visibility, Willey tells investors in a research note. Sanofi's decision to terminate the sotagliflozin licensing and collaborative agreement creates "even more uncertainty" for a story which, following FDA's Complete Response Letter for a potential Type-1 diabetes label, "already lacked meaningful visibility," says the analyst.
07/30/19
SBSH
07/30/19
NO CHANGE
Target $3
SBSH
Buy
Citi cuts Lexicon target to $3 from $15, still sees value in sotagliflozin
Citi analyst Yigal Nochomovitz lowered his price target for Lexicon Pharmaceuticals (LXRX) to $3 from $15 while keeping a Buy rating on the shares. The analyst believes Sanofi's (SNY) decision to terminate the partnership reflects to a greater extent Sanofi's prioritization of the internal pipeline and renewed focus on core areas versus specific liabilities regarding sotagliflozin. He still sees see some value in sotagliflozin and thinks shares of Lexicon are worth $3, well above yesterday's closing price of $1.69.
08/01/19
WEDB
08/01/19
NO CHANGE
Target $17
WEDB
Outperform
Lexicon price target lowered to $17 from $35 at Wedbush
Wedbush analyst Liana Moussatos lowered her price target for Lexicon (LXRX) to $17 from $35 to reflect a reduction in Zynquist sales projections. On July 26, partner Sanofi (SNY) announced the intent to terminate the diabetes partnership for Zynquista, which Lexicon indicated was due to not achieving statistical significance for the primary endpoint of reducing placebo-adjusted HbA1c in T2D patients with stage 3b/4 CKD, she contends, adding that Lexicon commented that there were strong trends favoring Zynquista in these patients and is disputing the termination. Moussatos reiterates an Outperform rating on Lexicon's shares.
09/11/19
SBSH
09/11/19
NO CHANGE
Target $3
SBSH
Buy
Lexicon settlement with Sanofi removes overhang, says Citi
Citi analyst Yigal Nochomovitz believes Lexicon Pharmaceuticals' (LXRX) settlement with Sanofi (SNY) removes an overhang and that the company's cash runway "may increase modestly." However, the funds are largely already spoken for with respect to continued funding of the core Phase 3 trials in n type 2 diabetes and the outcomes trials, Nochomovitz tells investors in a research note. The analyst keeps a Buy rating on Lexicon shares with a $3 price target.

TODAY'S FREE FLY STORIES

YCBD

cbdMD

$4.99

0.27 (5.72%)

12:35
09/20/19
09/20
12:35
09/20/19
12:35
Hot Stocks
cbdMD discloses presentation in conjunction with convertible preferred offering »

cbdMD disclosed in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.41

-0.24 (-3.14%)

12:35
09/20/19
09/20
12:35
09/20/19
12:35
Options
USA Technologies put volume heavy and directionally bearish »

Bearish flow noted in USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKR

Timken

$44.78

0.41 (0.92%)

12:34
09/20/19
09/20
12:34
09/20/19
12:34
Conference/Events
Timken management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

BPL

Buckeye Partners

$41.15

-0.035 (-0.08%)

12:34
09/20/19
09/20
12:34
09/20/19
12:34
Hot Stocks
Buckeye Partners says Buckeye Bahamas Hub resumes full operations »

Buckeye Partners reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRLCY

L'Oreal

$0.00

(0.00%)

12:34
09/20/19
09/20
12:34
09/20/19
12:34
Hot Stocks
L'Oreal announces settlement with French tax authorities »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$50.55

0.01 (0.02%)

12:33
09/20/19
09/20
12:33
09/20/19
12:33
Conference/Events
SS&C management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.20

0.523619 (0.17%)

12:31
09/20/19
09/20
12:31
09/20/19
12:31
General news
Trump says he can leave IP out and get China deal done »

President Trump said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.20

0.523619 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEFT

Euronet

$147.35

0.92 (0.63%)

12:27
09/20/19
09/20
12:27
09/20/19
12:27
Conference/Events
Euronet participates in a conference call with Northland »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 14

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.20

0.523619 (0.17%)

12:27
09/20/19
09/20
12:27
09/20/19
12:27
Hot Stocks
Trump says China buying ag products not enough for trade deal »

President Trump said in…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.20

0.523619 (0.17%)

ADM

Archer Daniels

$41.10

0.21 (0.51%)

AGU

Agrium

$0.00

(0.00%)

CF

CF Industries

$49.97

-0.07 (-0.14%)

MON

Bought by BAYRY

$0.00

(0.00%)

POT

Potash

$0.00

(0.00%)

ANDE

Andersons

$26.45

-0.39 (-1.45%)

SYT

Syngenta

$0.00

(0.00%)

BG

Bunge

$56.02

-0.15 (-0.27%)

IPI

Intrepid Potash

$3.41

-0.01 (-0.29%)

CMP

Compass Minerals

$57.07

-0.985 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 06

    Nov

  • 13

    Nov

REGN

Regeneron

$295.39

9.11 (3.18%)

12:25
09/20/19
09/20
12:25
09/20/19
12:25
Options
Regeneron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$8.95

0.04 (0.45%)

12:25
09/20/19
09/20
12:25
09/20/19
12:25
Conference/Events
Cowen retail/luxury analyst to hold an analyst/industry conference call »

Retail & Luxury Goods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

12:25
09/20/19
09/20
12:25
09/20/19
12:25
Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call »

Healthcare Analysts host…

MGI

MoneyGram

$4.94

0.075 (1.54%)

12:24
09/20/19
09/20
12:24
09/20/19
12:24
Conference/Events
MoneyGram participates in a conference call with Northland »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

YCBD

cbdMD

$5.03

0.31 (6.57%)

12:19
09/20/19
09/20
12:19
09/20/19
12:19
Hot Stocks
Breaking Hot Stocks news story on cbdMD »

cbdMD trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/20/19
09/20
12:17
09/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
09/20/19
09/20
12:16
09/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONO

Sonos

$15.01

-0.065 (-0.43%)

12:15
09/20/19
09/20
12:15
09/20/19
12:15
Options
Sonos put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRAM

Everspin Technologies

$6.52

-0.09 (-1.36%)

12:12
09/20/19
09/20
12:12
09/20/19
12:12
Conference/Events
Everspin Technologies management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 12

    Nov

SAIC

SAIC

$84.64

0.76 (0.91%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Recommendations
SAIC analyst commentary  »

SAIC recompete bid on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$86.18

1.5 (1.77%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Conference/Events
Alnylam management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

  • 04

    Feb

SNPS

Synopsys

$137.26

0.09 (0.07%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Synopsys management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

TYL

Tyler Technologies

$259.35

-0.22 (-0.08%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Tyler Technologies management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AAPL

Apple

$220.96

0.05 (0.02%)

, MCD

McDonald's

$210.55

-0.01 (-0.00%)

12:02
09/20/19
09/20
12:02
09/20/19
12:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are mixed at…

AAPL

Apple

$220.96

0.05 (0.02%)

MCD

McDonald's

$210.55

-0.01 (-0.00%)

FB

Facebook

$190.17

0.02 (0.01%)

MDR

McDermott

$2.70

1.12 (70.89%)

CRC

California Resources

$11.86

1.96 (19.80%)

ROKU

Roku

$114.30

-19.41 (-14.52%)

W

Wayfair

$123.39

-5.275 (-4.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Oct

SCS

Steelcase

$18.34

1.57 (9.36%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
Steelcase rises 9.6% »

Steelcase is up 9.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 15

    Oct

  • 16

    Oct

IBN

ICICI Bank

$11.88

1.11 (10.31%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
ICICI Bank rises 10.2% »

ICICI Bank is up 10.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.